MedPath

Treatment of refractory depression using NeuroStar TMS Therapy System and a predictor of the treatment response: a comprehensive, exploratory study through neurobiological, neurophysiological, and neuroimaging approaches

Not Applicable
Conditions
Major depressive disorder
Registration Number
JPRN-UMIN000007611
Lead Sponsor
Department of Neuropsychiatry, Kyorin University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1. Psychotic episode, bipolar disorder, OCD, PTSD, eating disorder 2. Previous treatment with ECT, TMS, VNS, DBS, tDCS 3. Pregnancy 4. Personal or close family history of seizure disorder 5. Neurologic disorder, organic brain disease 6. Substance or alcohol dependence 7. Ferromagnetic material in body or close to head 8. Severe metabolic disease, endocrine disease 9. Active suicide idea 10. Taking medications known to lower seizure threshold

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HAMD 17, HAMD 24, MADRS Severity of depression is rated with these scales every 2 weeks.
Secondary Outcome Measures
NameTimeMethod
CGI, YMRS
© Copyright 2025. All Rights Reserved by MedPath